Published in Brain Res Mol Brain Res on May 20, 2005
Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A (2007) 2.03
Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol (2009) 1.70
Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav Immun (2006) 1.26
Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerve. J Neuroinflammation (2010) 1.14
Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain (2010) 1.11
Chemokines as pain mediators and modulators. Curr Opin Anaesthesiol (2008) 1.04
Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain. Histochem Cell Biol (2010) 1.02
Intra- and extraneuronal changes of immunofluorescence staining for TNF-alpha and TNFR1 in the dorsal root ganglia of rat peripheral neuropathic pain models. Cell Mol Neurobiol (2006) 1.00
Bilateral hand/wrist heat and cold hyperalgesia, but not hypoesthesia, in unilateral carpal tunnel syndrome. Exp Brain Res (2009) 0.95
Bilateral nerve alterations in a unilateral experimental neurotrophic keratopathy model: a lateral conjunctival approach for trigeminal axotomy. PLoS One (2013) 0.90
Chronic neuropathic pain-like behavior and brain-borne IL-1β. Ann N Y Acad Sci (2012) 0.90
Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model. J Histochem Cytochem (2013) 0.90
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism. Mediators Inflamm (2013) 0.90
Bilateral elevation of interleukin-6 protein and mRNA in both lumbar and cervical dorsal root ganglia following unilateral chronic compression injury of the sciatic nerve. J Neuroinflammation (2013) 0.90
Spinal interleukin-10 therapy to treat peripheral neuropathic pain. Neuromodulation (2012) 0.88
Role of TNF-alpha during central sensitization in preclinical studies. Neurol Sci (2011) 0.87
Cytokine responses during chronic denervation. J Neuroinflammation (2005) 0.86
Bilateral changes in IL-6 protein, but not in its receptor gp130, in rat dorsal root ganglia following sciatic nerve ligature. Cell Mol Neurobiol (2009) 0.85
Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury. J Neuroinflammation (2015) 0.84
Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release. Neuropharmacology (2006) 0.79
A heterogeneous immunofluorescence staining for laminin-1 and related basal lamina molecules in the dorsal root ganglia following constriction nerve injury. Histochem Cell Biol (2005) 0.78
CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model. J Neuroinflammation (2016) 0.78
Molecular Assessment of Neuroregenerative Response in the Pudendal Nerve: A Useful Tool in Regenerative Urology. SDRP J Biomed Eng (2016) 0.75
[Cytokine regulation and pain. Results of experimental and clinical research]. Schmerz (2008) 0.75
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene (1996) 2.73
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke (2003) 2.44
[Definition, classification and diagnosis of fibromyalgia syndrome]. Schmerz (2008) 2.38
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med (2013) 1.96
Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J Neuroimmunol (1994) 1.85
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1997) 1.73
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 1.63
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke (2000) 1.55
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2012) 1.55
Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab (1995) 1.50
Fever as sole and delayed manifestation of azathioprine hypersensitivity. Muscle Nerve (1996) 1.44
The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol (2001) 1.43
Von Willebrand disease caused by compound heterozygosity for p.r854q and p.r760c: diagnostic and therapeutic implications. Haemophilia (2010) 1.39
Mixed axonal-demyelinating polyneuropathy as predominant manifestation of myotonic dystrophy. Muscle Nerve (1994) 1.39
Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest (1996) 1.38
Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia. Stroke (1997) 1.20
Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population. Sleep (2009) 1.19
A new correlation-based fuzzy logic clustering algorithm for fMRI. Magn Reson Med (1998) 1.12
Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri. Stroke (2001) 1.12
Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience (2008) 1.11
The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol (2004) 1.08
Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol (1992) 1.08
Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke (1998) 1.07
Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol (1991) 1.06
Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett (2001) 1.06
Fracture of the lateral process of the talus in snowboarders. J Bone Joint Surg Br (2007) 1.06
Delayed and remote effects of focal cortical infarctions: secondary damage and reactive plasticity. Adv Neurol (1997) 1.05
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol (2006) 1.04
Small-fiber neuropathy in patients with ALS. Neurology (2011) 1.04
In vivo imaging of inflammation in the peripheral nervous system by (19)F MRI. Exp Neurol (2011) 1.02
Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res (2000) 1.02
Desmin and actin associated with cytoplasmic bodies in skeletal muscle fibers: immunocytochemical and fine structural studies, with a note on unusual 18- to 20-nm filaments. Acta Neuropathol (1990) 1.02
Small fibre neuropathy in sarcoidosis. Lancet (2002) 1.01
Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab (2001) 1.01
Degradation of 1,4-dichlorobenzene by Xanthobacter flavus 14p1. Appl Environ Microbiol (1995) 0.99
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
New techniques in indirect reduction of long bone fractures. Clin Orthop Relat Res (1998) 0.97
Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke (2001) 0.97
Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. AJNR Am J Neuroradiol (2001) 0.96
Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex. Neuroscience (1999) 0.96
A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology (2005) 0.96
Foot movement and tendon excursion: an in vitro study. Foot Ankle Int (1994) 0.95
Spatiotemporal relationship of apoptotic cell death to lymphomonocytic infiltration in photochemically induced focal ischemia of the rat cerebral cortex. Acta Neuropathol (1996) 0.95
Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am J Pathol (1998) 0.95
Enhanced cortical reperfusion protects coagulation factor XII-deficient mice from ischemic stroke as revealed by high-field MRI. Neuroimage (2009) 0.95
Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol (1999) 0.95
Application of compressed sensing to in vivo 3D ¹⁹F CSI. J Magn Reson (2010) 0.94
Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia. J Neuroimmunol (2000) 0.93
Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol (2005) 0.93
Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. Anticancer Res (2004) 0.93
Scaling of pitch strength. Hear Res (1979) 0.93
Munc13-4-mediated secretion is essential for infarct progression but not intracranial hemostasis in acute stroke. J Thromb Haemost (2013) 0.93
Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J Immunol (2000) 0.93
Molecular mechanisms of cellular interactions in peripheral nerve regeneration. Curr Opin Neurol (2001) 0.93
Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury. Neurosci Lett (1986) 0.92
Effect of global system for mobile communication (GSM) microwave exposure on blood-brain barrier permeability in rat. Acta Neuropathol (1997) 0.92
Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Neuroscience (2010) 0.92
Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. Int J Obes (Lond) (2010) 0.92
Methodology for spinal neurotoxicity studies. Reg Anesth (1994) 0.91
Dynamic changes of magnetic resonance imaging abnormalities in relation to inflammation and glial responses after photothrombotic cerebral infarction in the rat brain. Acta Neuropathol (2001) 0.91
Focal ischaemia of the rat brain elicits an unusual inflammatory response: early appearance of CD8+ macrophages/microglia. Eur J Neurosci (1998) 0.90
Plate fixation of proximal humerus fractures using the minimally invasive anterolateral delta split approach. Oper Orthop Traumatol (2012) 0.90
Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol (1990) 0.90
The characterization of Ia expression during Sindbis virus encephalitis in normal and athymic nude mice. J Neuropathol Exp Neurol (1990) 0.90
Protein S-100B: a serum marker for ischemic and infectious injury of cerebral tissue. Clin Chem Lab Med (2001) 0.90
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain. Curr Med Res Opin (2013) 0.90
Regulation of PDGF and PDGF receptor in cultured dermal papilla cells and follicular keratinocytes of the human hair follicle. Exp Dermatol (2003) 0.89
Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology (2003) 0.89
Differential regulation of Bax, Bcl-2, and Bcl-X proteins in focal cortical ischemia in the rat. Brain Pathol (1998) 0.89
Severe depletion of intraepidermal nerve fibers in skin biopsies of pancreas transplant recipients. Transplant Proc (2005) 0.89
Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology (2005) 0.89
On the parameterization of rigid base and basepair models of DNA from molecular dynamics simulations. Phys Chem Chem Phys (2009) 0.89
Storage and adiabatic cooling of polar molecules in a microstructured trap. Phys Rev Lett (2011) 0.89
Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxin. Muscle Nerve (1998) 0.88
Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia. Exp Neurol (2007) 0.88
Nerve injury and regeneration: basic insights and therapeutic interventions. Curr Opin Neurol (1998) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction. Brain Res (2000) 0.87
Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res (1996) 0.87
Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines. Ann Neurol (1986) 0.87
Expression of synaptopodin, an actin-associated protein, in the rat hippocampus after limbic epilepsy. Brain Pathol (2001) 0.86
Resistance to benzimidazole anthelmintics in small strongyles (Cyathostominae) of horses in Denmark. Acta Vet Scand (1991) 0.86
Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis. Ann Neurol (1990) 0.86
Dietary exposure to a low dose of pesticides alone or as a mixture: the biological metabolic fingerprint and impact on hematopoiesis. Toxicology (2013) 0.86
Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons. Neurobiol Dis (2009) 0.86
Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. J Neurosci Res (1994) 0.86